Alsa Research LLC

1. Pfizer Inc. $2,918,205 166 payments
2. AbbVie, Inc. $1,160,327 144 payments
3. BioNTech SE $265,735 71 payments
4. Regeneron Pharmaceuticals, Inc. $119,549 30 payments
5. Moderna TX, Inc. $47,564 20 payments
6. Sanofi US Services Inc. $44,738 18 payments
7. Noven Pharmaceuticals, Inc. $6,450 1 payment
8. Sun Pharmaceutical Industries Inc. $5,421 4 payments
9. E.R. Squibb & Sons, L.L.C. $1,355 1 payment

1. A Phase 3 Randomized Placebocontrolled Observerblinded Trial to Evaluate the Safety of A 6Valent Ospabased Lyme Disease Vaccine Vla15 in Healthy Children 5 Through 17 Years of Age $1,182,286 52 payments
2. A Phase 3 Randomized Observerblinded Study to Evaluate the Efficacy Safety Tolerability and Immunogenicity of A Modified Rna Vaccine Against Influenza Compared to Licensed Inactivated Influenza Vaccine in Healthy Adults 18 Years of Age Or Older $1,022,808 57 payments
3. A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants $775,524 38 payments
4. A Phase 3 Study to Evaluate the Efficacy Immunogenicity and Safety of Respiratory Syncytial Virus RSV Prefusion F Subunit Vaccine in Adults $500,386 30 payments
5. Bnt162-17 $218,722 40 payments
6. M21-341 - A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants $117,357 7 payments
7. Phase 3 Randomized, Double-Blind, Multi-Dose, Placebo and Nsaid Controlled Study to Evaluate the Efficacy and Safety of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee Or Hip $114,219 28 payments
8. M15-572 $112,650 44 payments
9. A Phase 3 Master Protocol to Evaluate the Safety Tolerability and Immunogenicity of Respiratory Syncytial Virus RSV Prefusion F Subunit Vaccine in Adults at High Risk of Severe RSV Disease $90,877 13 payments
10. A Phase 2/3 Multicenter, Double Blinded, Randomized, Dose-conversion, Active Control Study Examining the Efficacy and Safety of Armour Thyroid Compared to Synthetic T4 for the Treatment of Adults With Primary Hypothyroidism $58,639 4 payments

1. Patient care $47,013 31 payments

Only reported on some payments, and a payment can report more than one category, so these amounts overlap.